"Leukoplakia, Oral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of Epstein-Barr virus is present, the condition is called hairy leukoplakia (LEUKOPLAKIA, HAIRY).
| Descriptor ID |
D007972
|
| MeSH Number(s) |
C04.588.443.591.545 C04.834.512.513 C07.465.565.545 C23.300.816.513
|
| Concept/Terms |
Leukoplakia, Oral- Leukoplakia, Oral
- Leukoplakias, Oral
- Oral Leukoplakia
- Oral Leukoplakias
Leukokeratosis, Oral- Leukokeratosis, Oral
- Leukokeratoses, Oral
- Oral Leukokeratoses
- Oral Leukokeratosis
- Keratosis, Oral
|
Below are MeSH descriptors whose meaning is more general than "Leukoplakia, Oral".
Below are MeSH descriptors whose meaning is more specific than "Leukoplakia, Oral".
This graph shows the total number of publications written about "Leukoplakia, Oral" by people in this website by year, and whether "Leukoplakia, Oral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukoplakia, Oral" by people in Profiles.
-
Identification and characterization of novel ACD variants: modulation of TPP1 protein level offsets the impact of germline loss-of-function variants on telomere length. Cold Spring Harb Mol Case Stud. 2021 02; 7(1).
-
Oral premalignancy: the roles of early detection and chemoprevention. Otolaryngol Clin North Am. 2013 Aug; 46(4):579-97.
-
Optimizing biomarkers and endpoints in oral cancer chemoprevention trials. Cancer Prev Res (Phila). 2013 May; 6(5):375-8.
-
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clin Cancer Res. 2011 Dec 01; 17(23):7248-64.
-
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer. Cancer Prev Res (Phila). 2010 Jul; 3(7):800-9.
-
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res. 2009 Oct 01; 15(19):6284-91.
-
High-dose fenretinide in oral leukoplakia. Cancer Prev Res (Phila). 2009 Jan; 2(1):22-6.
-
Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias. Oral Oncol. 2008 Aug; 44(8):753-8.
-
Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res. 2006 May 15; 12(10):3109-14.
-
The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med. 2004 Apr 01; 350(14):1405-13.